Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bonesupport Holding AB (publ) (BOEUF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.880.00 (0.00%)
At close: 09:46AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.88
Open5.88
BidN/A x N/A
AskN/A x N/A
Day's Range5.88 - 5.88
52 Week Range3.83 - 6.90
Volume5,000
Avg. Volume47
Market Cap456.683M
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BOEUF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BONESUPPORT HOLDING AB
    Analyst Report: Capital One Financial CorporationCapital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial’s credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
    Rating
    Fair Value
    Economic Moat
    3 months agoMorningstar
View more
  • PR Newswire

    MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA

    MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Cybersecurity is pleased to announce its role in the granting of the DeNovo by the U.S. Food and Drug Administration (FDA) for BONESUPPORT'S CERAMENT G, an implantable device/drug combination bone void filler that provides a one-stage approach for the management of bo

Advertisement
Advertisement